CHRW
45
3
FLS
68
3
AKAM
56
2
FOXA
37
2
NTRS
50
8
GE
65
4
EXPE
74
8
ZION
59
7
ROK
43
3
AN
46
2
C
58
3
HST
50
6
WMB
68
4
COST
53
3
ADT
46
5
KMI
61
4
DIS
52
4
RF
45
4
TSCO
62
2
PRGO
32
3
CHRW
45
3
FLS
68
3
AKAM
56
2
FOXA
37
2
NTRS
50
8
GE
65
4
EXPE
74
8
ZION
59
7
ROK
43
3
AN
46
2
C
58
3
HST
50
6
WMB
68
4
COST
53
3
ADT
46
5
KMI
61
4
DIS
52
4
RF
45
4
TSCO
62
2
PRGO
32
3
Financhill
Back

Petros Pharmaceuticals 10K Form

Sell
37

PTPI
Petros Pharmaceuticals

Last Price:
0.35
Seasonality Move:
8.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PTPI News And Ratings

See the #1 stock for the next 7 days that we like better than PTPI

PTPI Financial Statistics

Sales & Book Value

Annual Sales: $5.82M
Cash Flow: $-1.66M
Price / Cash Flow: 0
Annual Sales: $0.87
Price / Book: 0.42

Profitability

EPS (TTM): -6.54000
Net Income (TTM): $-7.06M
Gross Margin: $4.19M
Return on Equity: -67.38%
Return on Assets: -22.48%

Petros Pharmaceuticals Earnings Forecast

Key Petros Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 5 years for PTPI is 71.98%.
  • The Selling, General & Administrative Expenses for PTPI have been equal to 159.07% of Gross Profit Margin.
  • The Research & Development expenses have been 41.38% of Revenue.
  • The Interest Expense is -6.57% of Operating Income.
  • The Net Earning history of PTPI is -140.20% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Petros Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: PTPI
CUSIP: 71678J
Website: petrospharma.com

Debt

Debt-to-Equity Ratio: 0.83
Current Ratio: 1.4
Quick Ratio: 0.93

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PTPI Technical Analysis vs Fundamental Analysis

Sell
37
Petros Pharmaceuticals (PTPI) is a Sell

Is Petros Pharmaceuticals a Buy or a Sell?